Bausch Health Companies | Ventas



Sales Cambio Fecha
Amgen USD 9.09B 583M 2024-12
ANI Pharmaceuticals USD 190.6M 42.3M 2024-12
Aurora Cannabis CAD 88.2M 7.08M 2024-12
Bausch Health Companies USD 2.56B 50M 2024-12
Biogen USD 2.45B 11.1M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Canopy Growth CAD 74.76M 11.77M 2024-12
Corcept Therapeutics USD 181.89M 656K 2024-12
Danaher USD 6.54B 740M 2024-12
Drreddys Laboratories INR 83.59B 3.42B 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
Novo Nordisk 85.68B 14.37B 2024-12
Pacira USD 187.25M 18.68M 2024-12
Perrigo USD 1.14B 50.8M 2024-12
Prestige Brands USD 290.32M 6.53M 2024-12
Supernus Pharmaceuticals USD 174.16M 1.53M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12
Zoetis USD 2.32B 71M 2024-12



Bausch Health Companies Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.